ArriVent BioPharma (AVBP) Return on Equity [ROE] (2024 - 2026)
ArriVent BioPharma (AVBP) recorded Return on Equity [ROE] of -47.40% in Q2 2026, up 13.15 percentage points from -60.56% a year earlier but down 1.38 percentage points from the prior quarter.
Powered by 
Analysis
ArriVent BioPharma (AVBP) Return on Equity [ROE] (2024 - 2026) Analysis & Trends
For FY2025, ArriVent BioPharma reported Return on Equity [ROE] of -58.88%, up 95.22 percentage points from FY2024.
- Across earlier years, Return on Equity [ROE] came in at -154.10% in FY2024.
- Quarterly Return on Equity [ROE] has ranged from -90.66% in Q1 2024 to -24.38% in Q2 2024 over the past five years.
- On a year-over-year basis, Return on Equity [ROE] rose in three of the last six quarters, with an average year-over-year change of -4.83 percentage points.
- Per Business Quant, the preceding three quarters came in at -46.02% (Q1 2026), -54.33% (Q4 2025) and -54.57% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | ArriVent BioPharma | 690.85 Mn | -714.69 Mn | - | -44.65% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -44.65% |
| Jun 30, 2026 | -47.48% |
| Mar 31, 2026 | -46.10% |
| Dec 31, 2025 | -54.26% |
| Sep 30, 2025 | -54.50% |
| Jun 30, 2025 | -60.56% |
| Mar 31, 2025 | -55.40% |
| Dec 31, 2024 | -30.16% |
| Sep 30, 2024 | -28.23% |
| Jun 30, 2024 | -24.38% |
| Mar 31, 2024 | -90.66% |
API Access
ArriVent BioPharma Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=AVBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "AVBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=AVBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();